What is the fair value of Sofgen Pharma SA (OTC-PROC.F) stock?

A fair value estimate for Sofgen Pharma SA (OTC-PROC.F) is not currently available in the latest data file.

Is Sofgen Pharma SA (OTC-PROC.F) undervalued or overvalued?

A clear undervalued or overvalued classification is not currently available in the latest data file.

What is the analyst price target for OTC-PROC.F stock?

An analyst price target for Sofgen Pharma SA (OTC-PROC.F) is not currently available in the latest data file.

How is the financial health of Sofgen Pharma SA?

The current financial health read for Sofgen Pharma SA (OTC-PROC.F) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Sofgen Pharma SA's next earnings date?

The next earnings date currently listed for Sofgen Pharma SA (OTC-PROC.F) is September 8, 2026.

Does Sofgen Pharma SA (OTC-PROC.F) pay dividends?

Based on the current data, dividend yield is 0.0%.

What is the market capitalization of Sofgen Pharma SA?

The current market capitalization listed for Sofgen Pharma SA is 58.353 M.

What is the ticker symbol for Sofgen Pharma SA?

The ticker symbol for Sofgen Pharma SA is OTC-PROC.F, and the stock is listed on OTC Markets.

Where is Sofgen Pharma SA (OTC-PROC.F) listed?

Sofgen Pharma SA (OTC-PROC.F) is listed on OTC Markets.

Sofgen Pharma SA (PROCF) Fair Value & Stock Analysis

Sofgen Pharma SA (PROCF)

Sofgen Pharma S.A. is a Luxembourg-based pharmaceutical company listed on OTC Markets as common stock. Through its subsidiaries, the company develops, manufactures, and sells pharmaceutical products and healthcare solutions across South America, Central America, North America, and Europe. Its operations are organized into five segments: NextGel, Procaps Colombia, Central America North, Central America South and North Andes, and Diabetrics.

The company’s portfolio includes softgel technologies and related products sold under brands such as Softigel, Sofgen, Softcaps, and Funtrition. It also markets branded prescription medicines, hospital-use high-complexity drugs, and over-the-counter consumer healthcare products. In addition, Sofgen Pharma develops diabetes-related products and medical delivery items, including blood glucose meters, insulin delivery systems, syringes, and sterile pharmaceutical packaging and dosage forms. The company was formerly known as Procaps Group S.A. and was founded in 1977.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Upcoming Dividend Ex-Date	Dividend Payment Date	Upcoming Dividend	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
OTC-PROC.F	—	—	—	—	—	—	Weak	—	—	—	0.0%	September 8, 2026	—	—	—	58.353 M	—	—	—	—	—	—